The Straumann Group is a global leader in implant dentistry and restorative solutions. Headquartered in Basel, Switzerland, the company develops, manufactures and distributes dental implants, prosthetic components and complementary biomaterials. Its portfolio spans a range of products designed to support oral surgery, restorative dentistry and digital workflows, including implant systems, surgical instruments, bone grafting materials and tissue regenerators.
Complementing its core implant business, Straumann has expanded into digital dentistry and orthodontics. The company offers intraoral scanners, 3D printing solutions and milling machines that enable dental professionals to design and fabricate crowns, bridges and custom abutments. Through its ClearCorrect subsidiary, Straumann provides clear aligner therapy, catering to both general practitioners and specialized orthodontists. Its products and services are utilized in more than 100 markets across Europe, North America, Latin America and Asia-Pacific.
Founded in 1954 as Institut Straumann in Waldenburg, Switzerland, the company has grown through sustained investment in research and development and strategic acquisitions. Key milestones include the introduction of the world’s first titanium screw-root dental implant and the integration of brands such as Neodent in Brazil and Anthogyr in France. These expansions have broadened Straumann’s geographic reach and diversified its offerings, reinforcing its position in both premium and emerging markets.
The company’s Executive Board is led by Chief Executive Officer Guillaume Daniellot, who oversees global operations and strategic initiatives. Reporting to an independent Board of Directors, the management team includes seasoned leaders in marketing, R&D, manufacturing and finance. Together, they guide Straumann’s mission to restore oral health and improve patients’ quality of life through innovative dental solutions.
AI Generated. May Contain Errors.
Free SAUHF Stock Alerts